QUICKLINKS AND VIEW OPITONS
Elavil (amitriptyline) increases risk of diabetes 43%
Tuesday, April 05, 2011 6:19 am Email this article
The antidepressant Elavil (amitriptyline) increases the risk of diabetes 43% according to an analysis by researchers from Charité University Medical Center in Berlin, Germany.
The dose was 38 mg per day or above that increased the risk. Those who had taken the drug for 2 years or more
Those who had taken the drug for 2 years or more versus those who had not taken an antidepressant in the previous two years
The study compared the risk of diabetes in people who had taken antidepressants for 2 years or more compared to those had not taken an antidepressants during the previous two years.
Subjects: 165,958 patients
The analysis looked at “165,958 patients with depression who received at least one new prescription for an antidepressant between January 1, 1990, and June 30, 2005”.
Conclusion: Long-term use of antidepressants increases risk of diabetes
“Long-term use of antidepressants in at least moderate daily doses was associated with an increased risk of diabetes. This association was observed for both tricyclic antidepressants and selective serotonin reuptake inhibitors,” the researchers concluded.
Andersohn F, Schade R, Suissa S, Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry. 2009 May, 166(5):591-98.
AUTHOR’S CONTACT INFORMATION
Frank Andersohn, MD
Bremen Institute for Prevention Research and Social Medicine
Epidemiology, and Health Economics
Charité University Medical Center
10098 Berlin, Germany
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.